DFFVX
Price
$37.14
Change
+$0.59 (+1.61%)
Updated
Dec 3 closing price
Net Assets
13.9B
UBVAX
Price
$81.62
Change
+$0.70 (+0.87%)
Updated
Dec 3 closing price
Net Assets
9.24B
Interact to see
Advertisement

DFFVX vs UBVAX

Header iconDFFVX vs UBVAX Comparison
Open Charts DFFVX vs UBVAXBanner chart's image
DFA US Targeted Value I
Price$37.14
Change+$0.59 (+1.61%)
VolumeN/A
Net Assets13.9B
Undiscovered Managers Behavioral Val A
Price$81.62
Change+$0.70 (+0.87%)
VolumeN/A
Net Assets9.24B
DFFVX vs UBVAX Comparison Chart in %
View a ticker or compare two or three
VS
DFFVX vs. UBVAX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFFVX is a StrongBuy and UBVAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFFVX has more cash in the bank: 13.9B vs. UBVAX (9.24B). DFFVX pays higher dividends than UBVAX: DFFVX (1.65) vs UBVAX (1.56). DFFVX was incepted earlier than UBVAX: DFFVX (26 years) vs UBVAX (22 years). UBVAX (1.35) is less costly to investors than DFFVX (0.30). UBVAX is a more actively managed with annual turnover of: 35.00 vs. DFFVX (7.00). DFFVX has a lower initial minimum investment than UBVAX: DFFVX (0) vs UBVAX (1000). DFFVX annual gain was more profitable for investors over the last year : -0.27 vs. UBVAX (-9.13). DFFVX return over 5 years is better than : 71.07 vs. UBVAX (41.14).
DFFVXUBVAXDFFVX / UBVAX
Total Expense Ratio0.291.2423%
Annual Report Gross Expense Ratio0.301.3522%
Fund Existence26 years22 years-
Gain YTD8.1590.5541,472%
Front LoadN/A5%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets13.9B9.24B150%
Annual Yield % from dividends1.651.56106%
Returns for 1 year-0.27-9.133%
Returns for 3 years26.661.292,064%
Returns for 5 years71.0741.14173%
Returns for 10 years79.5950.88156%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FPHAX31.64N/A
N/A
Fidelity Select Pharmaceuticals Port
POSKX41.51N/A
N/A
PRIMECAP Odyssey Stock
WSHFX67.66N/A
N/A
American Funds Washington Mutual F1
DNLDX65.03N/A
N/A
BNY Mellon Active MidCap A
TMITX10.92N/A
N/A
Transamerica Mid Cap Growth I3